Overview

The global Surgical Planning Software Market was valued at USD 800 million in 2025 and is projected to reach USD 1,965 million by 2034, growing at a CAGR of 10.5% during the forecast period (2026–2034). The market is driven by the rising volume of implant-based orthopedic, spine, cranial, and cardiovascular procedures, wider use of CT and MRI data in surgical preparation, and hospital demand for shorter operating times and fewer revision cases. The market is shifting from conventional and manual 2D templating on X-rays toward automated, AI-assisted 3D planning that produces a draft plan within minutes of a scan upload. Vendors are adding extended reality viewers, browser-based access, and open implant libraries, while device makers tie planning software to robots, navigation, and 3D-printed guides. Hospitals are also moving planning in house, so surgical teams can prepare complex cases without waiting days for an outside service. Government initiatives such as the US Food and Drug Administration's December 2024 final guidance on predetermined change control plans for AI-enabled device software functions allow developers to update cleared algorithms without filing a new submission for every change. In Europe, the Medical Device Regulation (EU) 2017/745 sets the certification route for planning software, and CE-certified products can be sold across member states. These frameworks give hospital buyers clearer evidence of safety and performance, which shortens procurement cycles. By region, North America held the largest share of the market in 2025, led by the United States, where high procedure volumes and early adoption of digital surgery keep demand strong. Asia-Pacific is expected to be the fastest-growing region during the forecast period, as hospital modernization in China, India, Japan, and South Korea expands the use of 3D planning in orthopedic and neurosurgical care.

Market Size & Share

Market Dynamics

KEY MARKET TREND

AI-Enabled Segmentation and Automated Plan Generation Emerging as a Transformational Trend

• Planning vendors are replacing manual image segmentation with machine-learning tools that turn CT and MRI scans into labeled 3D anatomy within minutes. Surgeons now review and adjust a draft plan instead of building one from scratch. This shift shortens case preparation, reduces dependence on specialist technicians, and gives every surgeon in a department a consistent starting point for complex cases.
• Cloud hosting, browser access, and PACS connectivity are making planning tools available on any hospital workstation without local installation. Extended reality viewers add a shared 3D view for surgeons, anesthesiologists, and patients during consultations. These choices lower the entry cost for community hospitals and allow multidisciplinary teams to review the same plan remotely before the day of surgery.
• Implant and robotics manufacturers are bundling planners with their implants, navigation, and guide services, while independent software firms compete on specialty coverage and open implant libraries. Neutral platforms that import templates from many manufacturers are gaining preference among hospitals that use several implant brands. Competitive pressure is pushing every vendor to add automation and procedure-specific modules.
• Sarasota Memorial Health Care System reported in May 2025 that its cancer surgeons use Ceevra's AI-assisted 3D models, built from standard CT and MRI scans, for planning and patient counseling. The hospital notes the technology received FDA authorization in 2018 for preoperative planning and intraoperative visualization. This shows how AI-based 3D planning has moved into routine oncology surgery.

KEY MARKET DRIVER

Rising Volume of Implant-Based and Image-Guided Procedures Driving Demand for Preoperative Planning

• Joint replacement, spine fusion, cranial, and structural heart procedures are growing as populations age and more patients seek surgery for chronic conditions. Each requires choices on implant size, position, or surgical trajectory before the first incision. Planning software gives surgeons measurable evidence from the patient's own scan, which makes it a core workflow step.
• Hospitals are under pressure to shorten operating-room time, cut implant waste, and avoid revision surgery. Accurate plans let teams confirm implant sizes, prepare the right instrument trays, and anticipate difficult anatomy before the patient is on the table. These operational gains give administrators a clear financial reason to fund planning licenses alongside imaging and navigation budgets.
• Robotic systems, navigation platforms, and 3D-printed patient-specific guides all depend on a digital plan as their starting input. As hospitals buy more of these systems, planning software becomes a required companion product. Device makers are therefore investing in planners that export directly to their robots and guides, which keeps software demand tied to the growth of image-guided surgery.
• Stryker's published Blueprint product material reports that planning with the software changed the surgeon's choice between anatomic and reverse shoulder implants in 14% of cases. A shift of that size in a core surgical decision shows why surgeons treat 3D planning as clinically meaningful. Evidence of this kind supports hospital purchasing and reinforces software adoption across arthroplasty.

KEY MARKET OPPORTUNITY

Expansion of In-House Hospital Planning and Point-of-Care 3D Programs Creating New Revenue Streams

• Hospitals are building in-house 3D planning programs so surgeons can prepare complex cases without waiting for outside services. This opens recurring revenue for vendors through enterprise licenses, annual subscriptions, and training packages. Each new program also creates demand for segmentation tools, viewers, and 3D printing integration, which lifts the value of every hospital account.
• Cardiovascular, thoracic, urologic, and oncologic surgery remain less penetrated than orthopedics and leave room for procedure-specific planners. Structural heart interventions, lung segmentectomy, and kidney or prostate tumor removal all benefit from 3D anatomy review before surgery. Vendors that add validated modules for these specialties can enter new departments inside hospitals they already serve.
• Ambulatory surgery centers and hospitals in Asia-Pacific, Latin America, and the Middle East are adopting cloud-based planning on a per-case or subscription basis, which avoids heavy upfront hardware costs. Investors find this model attractive because revenue scales with case volume and software margins stay high. Local partnerships with implant makers can speed entry into these regions.
• Materialise states that its Mimics platform is trusted by more than 500 hospitals worldwide for in-house planning, anatomical modeling, and patient-specific device design. That installed base shows that hospital-led 3D programs are already commercial at scale. It also points to a large group of smaller hospitals that have not yet started similar programs.

Surgical Planning Software Market Size, 2025-2034 (USD Million)

Segmentation Analysis

Analysis by Component

Software held the largest market share in 2025 because every planning workflow starts with a licensed application that handles image import, segmentation, measurement, implant templating, and plan reporting. Hospitals and implant companies buy these licenses as enterprise agreements or annual subscriptions, which creates a steady and repeatable revenue base. Software also carries the clinical and regulatory weight of the product, since it is the component that receives clearance as a medical device. Integration with imaging archives, robots, and navigation systems keeps customers on the same platform for years, and each new procedure module raises the revenue earned from an existing account.

Services are projected to grow at the fastest CAGR during the forecast period as hospitals look for help to start and run planning programs. Managed planning services, where trained engineers prepare the 3D plan from the surgeon's scan, suit centers that lack in-house technical staff. Implementation, integration with imaging archives, user training, and validation support are also in demand as hospitals deploy planning at scale. Per-case pricing allows smaller hospitals and ambulatory centers to adopt planning without large upfront spending, and AI-assisted workflows that still need clinical review are expected to keep service demand strong.

Component categories include

                    ·           Software (Dominating Segment)

                    ·           Services (Highest CAGR Segment)

Analysis by Deployment

On-Premise deployment held the largest market share in 2025 because hospitals handle sensitive imaging data and prefer to keep it inside their own networks. Local installation connects directly to picture archiving systems and operating-room displays, gives predictable performance for large CT and MRI files, and fits the information security policies that most large hospitals already follow. Many established planning products, especially those used in orthopedics and neurosurgery, were built for workstation use and remain licensed that way. The large installed base of workstations and the cost of changing tools in a busy surgical department keep on-premise systems in wide use.

Cloud-Based deployment is projected to grow at the fastest CAGR during the forecast period as hospitals and surgery centers look for planning access without new hardware. Browser-based tools allow surgeons to review a plan from the clinic, the operating room, or home, and let colleagues at other sites join the same case. Vendors can release updates, add AI models, and expand implant libraries without visiting each site, which improves product value over time. Subscription and per-case pricing also lower the entry cost for ambulatory surgical centers and hospitals in developing markets, and resistance to hosted planning is expected to fall as health systems move imaging archives online.

Deployment categories include

                    ·           On-Premise (Dominating Segment)

                    ·           Cloud-Based (Highest CAGR Segment)

Analysis by Application

Orthopedic Surgery held the largest market share in 2025 because joint replacement, trauma fixation, and spine procedures depend heavily on implant selection and alignment, which planning software supports directly. Orthopedic surgeons were early users of digital templating, and implant makers have built planners around their own product lines, which keeps adoption high. High procedure volumes for hip, knee, and shoulder replacement, together with the growth of robotic and patient-specific guide workflows that require a digital plan, add steady demand. Hospitals also use planning to reduce revision risk, a costly outcome in orthopedics, which strengthens the case for purchase.

Cardiovascular Surgery is projected to grow at the fastest CAGR during the forecast period as transcatheter and structural heart procedures increase and require detailed 3D anatomy review. Procedures such as valve replacement, left atrial appendage closure, and aortic repair involve tight anatomical margins where device sizing and positioning must be confirmed before the case. Planning tools that simulate device placement on CT data help teams reduce complications and procedure time. As cardiology departments adopt 3D printing and virtual reality for complex cases, adoption is expected to expand from early academic centers into community hospitals.

Application categories include

                    ·           Orthopedic Surgery (Dominating Segment)

                    ·           Neurosurgery

                    ·           Cardiovascular Surgery (Highest CAGR Segment)

                    ·           Craniomaxillofacial Surgery

                    ·           Others

Analysis by Technology

Image-Based 3D Planning held the largest market share in 2025 because it is the established method surgeons use to convert CT and MRI data into measurable 3D models for implant selection, cutting plane definition, and trajectory design. The approach is well understood, widely cleared by regulators, and supported by large implant libraries and training materials. Hospitals can use it across many specialties with the imaging equipment they already own. Most newer tools still build on this core workflow, so spending on image-based planning continues even when buyers add automation or visualization features on top.

Artificial Intelligence-Enabled Planning is projected to grow at the fastest CAGR during the forecast period as automated segmentation, landmark detection, and implant recommendation reduce the time needed to create a plan from hours to minutes. Surgeons review and approve a draft instead of building the plan manually, which suits busy surgical schedules. Regulators now accept update frameworks for AI software, so vendors can improve algorithms after clearance. Rising investment from implant makers and software developers, along with growing evidence on accuracy and time savings, is expected to make AI-assisted planning the default way plans are created.

Technology categories include

                    ·           Image-Based 3D Planning (Dominating Segment)

                    ·           Artificial Intelligence-Enabled Planning (Highest CAGR Segment)

                    ·           Extended Reality-Enabled Planning

                    ·           Others

Analysis by End User

Hospitals held the largest market share in 2025 because they perform most complex inpatient surgeries and own the imaging systems, operating rooms, and information technology teams needed to run planning software. Multi-specialty hospitals can spread license costs across orthopedic, neurosurgical, cardiovascular, and oncologic departments, which supports enterprise purchasing. Teaching hospitals also drive early use of new planning methods and publish outcome studies that influence other buyers. Strong capital budgets, links to implant and robotics suppliers, and the need to standardize surgical quality across many surgeons keep hospitals as the primary customer group.

Ambulatory Surgical Centers are projected to grow at the fastest CAGR during the forecast period as more joint replacement and spine procedures move from inpatient wards to outpatient settings. These centers run tight schedules and need predictable cases, and planning software helps them confirm implant needs and reduce unplanned changes on the day of surgery. Cloud-based and per-case pricing suit their limited technical staff and capital budgets. As payers encourage lower-cost sites of care and surgeons invest in centers, planning tools are expected to become standard equipment in outpatient surgical workflows.

End User categories include

                    ·           Hospitals (Dominating Segment)

                    ·           Ambulatory Surgical Centers (Highest CAGR Segment)

                    ·           Specialty Clinics

                    ·           Research Institutes

By Region

Surgical Planning Software Market Regional Analysis

Surgical Planning Software Market Share 2025, (CAGR)

North America

42%

South America

XX%

Europe

28%

Middle East Africa

XX%

Asia Pacific

XX%

Regional Analysis

North America held the largest market share in 2025, accounting for 42% of the global market. The United States leads the region with a high volume of joint replacement, spine, and neurosurgical procedures, a dense base of implant and software developers, and a US Food and Drug Administration pathway that has produced many clearances for planning and segmentation tools. Hospitals and ambulatory centers are adding 3D planning to support robotic surgery and patient-specific guides, and large health systems are standardizing planning across surgeons. Canada contributes through academic hospital programs that use extended reality and 3D modeling for complex cases, while Mexico is growing as private hospitals invest in digital surgery. Venture funding for AI imaging firms and partnerships between implant makers and software vendors keep the competitive landscape active.

Asia-Pacific is projected to grow at the fastest CAGR during the forecast period, rising from 24% of the global market in 2025 to about 31% by 2034. China is expanding hospital digitization and reviewing more domestic and imported planning software through the National Medical Products Administration, while its large patient base supports high surgical volumes. India is seeing rapid private hospital growth and wider use of cloud-based tools in orthopedic and neurosurgical centers. Japan applies strict quality standards through its Pharmaceuticals and Medical Devices Agency and leads in precise imaging and implant-specific templating, and South Korea has a strong medical device ecosystem with early adoption of robotic and AI-supported surgery. Partnerships between global vendors and regional distributors, together with growing surgeon training programs, are widening access across the region.

Countries and Regions Covered

North America (Dominating Region)

o  United States (Largest Country Market)

o  Canada

o  Mexico

Asia-Pacific (Fastest Growing Region)

o  China (Largest Country Market)

o  India (Fastest-Growing Country Market)

o  Japan

o  South Korea

o  Rest of Asia-Pacific

Europe

o  Germany (Largest Country Market)

o  France

o  United Kingdom

o  Italy

o  Rest of Europe

Latin America

o  Brazil (Largest Country Market)

o  Chile (Fastest-Growing Country Market)

o  Rest of Latin America

Middle East & Africa

o  Saudi Arabia (Largest Country Market)

o  United Arab Emirates (Fastest-Growing Country Market)

o  Rest of Middle East & Africa

Market Share

The Surgical Planning Software Market is fragmented, with large orthopedic and neurosurgical device makers such as Stryker, Zimmer Biomet, Medtronic, and Smith+Nephew competing alongside software specialists such as Materialise, Brainlab, Sectra, and mediCAD Hectec, and a growing group of AI-focused companies. Key success factors include regulatory clearances in the United States and Europe, breadth of implant libraries, accuracy of automated segmentation, and integration with imaging archives, robots, and navigation systems. Leading companies are prioritizing AI automation, cloud delivery, and procedure-specific modules in cardiovascular, craniomaxillofacial, and shoulder care. Partnerships between software developers and implant makers are common, including template sharing and co-developed planners, while acquisitions are used to add robotics and AI capabilities. Innovation is centered on faster plan generation, extended reality viewing, and links to 3D-printed patient-specific devices.

Key Players

                    ·           Materialise NV (Belgium)

                    ·           Brainlab SE (Germany)

                    ·           Stryker Corporation (US)

                    ·           Medtronic plc (Ireland)

                    ·           Zimmer Biomet Holdings, Inc. (US)

                    ·           Smith+Nephew plc (UK)

                    ·           3D Systems Corporation (US)

                    ·           Sectra AB (Sweden)

                    ·           Medacta International SA (Switzerland)

                    ·           mediCAD Hectec GmbH (Germany)

                    ·           Ceevra, Inc. (US)

                    ·           Peek Health, S.A. (PeekMed) (Portugal)

                    ·           Formus Labs Limited (New Zealand)

                    ·           Avatar Medical (France)

                    ·           Realize Medical Inc. (Canada)

Recent Market Developments

• In October 2025, Smith+Nephew launched its CORIOGRAPH Pre-Op Planning and Modeling Services for total shoulder arthroplasty in the United States on 1 October 2025. The service adds 3D CT-based planning with range-of-motion and impingement simulation, and it completes a planning portfolio that now covers hip, knee, and shoulder replacement.
• In October 2025, Sectra added Smith+Nephew 3D templates to its pre-operative planning solution for orthopaedic trauma. The company states that its 3D template library now covers nearly 80% of the orthopaedic trauma market, which makes the planner more useful for hospitals that use implants from several manufacturers.
• In December 2025, 3D Systems received FDA 510(k) clearance for expanded indications of its VSP Orthopedics virtual surgical planning platform, which now includes skeletally mature adolescents in addition to adults. The clearance removes the need for case-by-case compassionate-use approval in adolescent bone tumor and deformity cases and opens a new patient group to virtual planning and patient-specific guides.
• In April 2026, Avatar Medical announced FDA 510(k) clearance for Avatar Medical Vision on 28 April 2026, a software platform for 3D medical image processing, review, and surgical planning. The clearance is described as the first for software used with glasses-free 3D medical displays and supports Eonis Vision, a joint solution with Barco for shared 3D review of patient anatomy during consultations.

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What is Surgical Planning Software?

2

What is the CAGR of the Surgical Planning Software Market?

3

Which application leads the Surgical Planning Software Market?

4

Which deployment type dominates the Surgical Planning Software Market?

5

Which component has the highest market share?

6

What are the latest trends in the Surgical Planning Software Market?

7

Who are the end users of Surgical Planning Software?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates